IP Library Granted Patent US 9,809,796
Granted Patent B2
US 9,809,796 · App. 15/598,406 · Granted Nov 7, 2017

Animal protein-free media for cultivation of cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,809,796
App. No.
15/598,406
Granted
Nov 7, 2017
Kind
B2
Abstract

The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.

Claims (21)

1. A method for expressing a target protein, comprising the steps of:

a) providing a culture of cells into which a nucleic acid comprising a sequence encoding the target protein has been introduced;

b) culturing the cells in an animal protein-free cell culture medium comprising putrescine and at least one protein hydrolysate, wherein the hydrolysate is derived from a plant or yeast, and wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 0.5 to about 10 mg/L.

2. The method of claim 1 , wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 2 to about 8 mg/L.

3. The method of claim 1 , wherein the putrescine is present in the animal protein-free cell culture medium in a concentration ranging from about 2 to about 5 mg/L.

4. The method of claim 1 , wherein the putrescine is from a different source than the protein hydrolysate.

5. The method of claim 1 , wherein the target protein is selected from the group consisting of a biologically active part of a blood coagulation factor, a biologically active part of a protein involved in the production of red blood cells and angiogenesis, and a monoclonal antibody.

6. The method of claim 5 , wherein the target protein is Factor VIII or erythropoietin.

7. The method of claim 6 , wherein the target protein is Factor VIII.

8. The method of claim 1 , wherein the cells are selected from the group consisting of mammalian cells, insect cells, avian cell, bacterial cell, and yeast cells.

9. The method of claim 8 , wherein the mammalian cells are CHO or BHK cells.

10. The method of claim 1 , wherein the cell is a CHO cell and the target protein is Factor VIII, or the cell is a BHK cell and the target protein is erythropoietin, or the cell is an Epstein Barr virus transformed immortalized human B cell and the target protein is a human antibody.

11. The method of claim 10 , wherein the cell is a CHO cell and the target protein is Factor VIII.

12. The method of claim 1 , wherein the cells are cultivated by a method selected from the group consisting of batch-cultivation, feed-batch-cultivation, perfusion-cultivation, and chemostat-cultivation.

13. The method of claim 1 , wherein the animal protein-free cell culture medium further comprises cadaverine, spermidine, spermine, agmatine, or ornithine, or a combination thereof.

14. The method of claim 1 , wherein the protein hydrolysate is derived from cereal or soy.

15. The method of claim 1 , wherein the protein hydrolysate is soy hydrolysate in a concentration ranging from about 0.5 to 30 mg/L.

16. The method of claim 1 , wherein the protein hydrolysate is present in the animal protein-free cell culture medium in a total concentration ranging from about 0.05 (w/v) to about 5% (w/v) for all protein hydrolysates.

17. The method of claim 1 , wherein the cells express the target protein.

18. The method of claim 1 , further comprising the step of isolating the target protein from the animal protein-free cell culture medium.

19. The method of claim 18 , wherein the target protein is Factor VIII.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2017
From: GRILLBERGER, LEOPOLD; REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 043047/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2017
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 043257/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2017
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 043259/0492 →